Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Wenxin Zheng, Kinga B. Skowron, Jukes P. Namm, Byron Burnette, Christian Fernandez, Ainhoa Arina, Hua Liang, Michael T. Spiotto, Mitchell C. Posner, Yang-Xin Fu, Ralph R. Weichselbaum
Published Jun 7, 2016 · Vol. 7, No. 28 · pp. 43039-43051
Michaela C. Huber, Natalie Falkenberg, Stefanie M. Hauck, Markus Priller, Herbert Braselmann, Annette Feuchtinger, Axel Walch, Manfred Schmitt, Michaela Aubele
Published Jun 6, 2016 · Vol. 7, No. 28 · pp. 44062-44075
Ailin Falkmo Hansen, Elise Sandsmark, Morten Beck Rye, Alan J. Wright, Helena Bertilsson, Elin Richardsen, Trond Viset, Anna M. Bofin, Anders Angelsen, Kirsten M. Selnæs, Tone Frost Bathen, May-Britt Tessem
Published Jun 3, 2016 · Vol. 7, No. 27 · pp. 42071-42085
